All stock lists
Unlock the score
BlossomHill Therapeutics, Inc. (BLSM)
NASDAQ: BLSM · Real-Time Price · USD
Healthcare · Biotechnology
16.34+1.71 (+11.71%)
Insider Score
/ 100
BLSM Insider Score
BlossomHill Therapeutics, Inc. has a live Insider Score.
Scored on 7 qualifying trades from 6 insiders in the last 90 days.
BLSM Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q1 2025 |
|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Mar 31, 2025 |
| Revenue | 0.00 | 0.00 | 0.00 |
| Revenue Growth (YoY) | — | — | — |
| Cost of Revenue | 0.00 | 0.00 | 0.00 |
| Gross Profit | 0.00 | 0.00 | 0.00 |
| SG&A Expense | 3.31 M | 2.21 M | 1.88 M |
| R&D Expense | 21.36 M | 19.90 M | 9.57 M |
| Operating Expenses | 24.67 M | 22.11 M | 11.45 M |
| Operating Income | -24.67 M | -22.11 M | -11.45 M |
| Pretax Income | -23.76 M | -21.01 M | -10.48 M |
| Tax Provision | 0.00 | 0.00 | 0.00 |
| Net Income | -23.76 M | -21.01 M | -10.48 M |
| EPS (Basic) | -8.75 | -0.72 | -0.36 |
| EPS (Diluted) | -8.75 | -0.72 | -0.36 |
| Shares Outstanding | 27.14 M | 29.08 M | 29.08 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.